new concerns about the safety of Meridia (sibutramine)

There are new concerns about the safety of Meridia (sibutramine).

Italy is suspending sales...a consumer group in the U.S. is asking the FDA to take Meridia off the market.

All this stems from reports of serious cardiovascular effects...heart attacks, strokes, arrhythmias, and some deaths.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote